Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Eisenhut, D. Thieme, D. Schmid, S. Luederwald, S. Hans (Luton, United Kingdom; Kreischa, Munich, Germany). Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection. Eur Respir J 2011; 38: Suppl. 55, 1825

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 On tuberculosis and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020 Year: 2020 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 Mycobacterial non-tuberculosis infection in patients operated on for pulmonary tuberculosis Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Pulmonary tuberculosis relapse or atypical mycobacterium infection? Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 The latent tuberculosis infection among household contacts of newly diagnosed patients with sputum-positive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 142s Year: 2003